Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C. Ford, Damien Hindmarch, Alexandra Wright‐Hughes et al.|The Lancet|2023Cited by 138
Abstracts from the NIHR INVOLVE Conference 2017Delia Muir, Graham Rhodes, Clara Rübner Jørgensen et al.|Research Involvement and Engagement|2017Cited by 8